Results 61 to 70 of about 47,652 (101)

Ticagrelor or dipyridamole plus aspirin may be a promising antiplatelet therapy in patients with minor stroke or transient ischemic attack: a bayesian network meta-analysis. [PDF]

Front Pharmacol
Qin S, Gao S, Xu D, Zhang L, Luo Y, Guo S.   +5 more
europepmc   +1 more source

Implementing CYP2C19-guided clopidogrel therapy: a scoping review of pharmacogenomic testing services. [PDF]

Pharmacogenomics J
Patel TJ, Wehbe E, Hughes S, Patanwala AE, Kritharides L, Lal S, Patel S, Stocker SL.   +7 more
europepmc   +1 more source

Clopidogrel transfer into human milk: case series - a contribution from the ConcePTION project. [PDF]

Front Pharmacol
Van Neste M, Nauwelaerts N, Mols R, Krutsch K, Ceulemans M, Passier A, Smits A, Annaert P, Allegaert K.   +8 more
europepmc   +1 more source

Ticagrelor Compared to Clopidogrel in Acute Coronary Syndromes trial (TC4): a Bayesian pragmatic cluster randomized controlled trial. [PDF]

CMAJ
Kutcher SA, Dendukuri N, Dandona S, Nadeau L, Brophy JM.   +4 more
europepmc   +1 more source

Prevalence of Aspirin or Clopidogrel Pharmacological Resistance in Ischemic Stroke: A Step Toward Precision Medicine. [PDF]

CNS Neurosci Ther
Cencer S, Packard L, Davis A, Ahrar A, Miller M, Khan N, Wees N, Min J.   +7 more
europepmc   +1 more source

The Type of Preoperative Oral Antithrombotics as a Risk Factor for Venous Thromboembolism After Hip Surgery: A Retrospective Study. [PDF]

Medicina (Kaunas)
Lee YJ, Lee J, Hong SW, Kim SH.
europepmc   +1 more source

Abbreviated dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials. [PDF]

BMC Cardiovasc Disord
Soleimani H, Karimi E, Mahalleh M, Entezari FJ, Nasrollahizadeh A, Nasrollahizadeh A, Rafiee H, Kalhor P, Al-Azizi KM, Rios LHP, Aronow WS, Ambrosy AP, Hosseini K.   +12 more
europepmc   +1 more source

Perioperative Antithrombotic Strategies in Vascular Surgery: A Survey in Germany. [PDF]

Health Sci Rep
Dovzhanskiy DI, Bischoff MS, Passek K, Böhner H, Böckler D.   +4 more
europepmc   +1 more source

Phase 1 study of novel anti-platelet agent to overcome pharmacogenomic limitations of clopidogrel. [PDF]

Open Heart
Pareek A, Chandurkar N, Raut V, Naidu K.
europepmc   +1 more source

Study of clopidogrel and clonidine interactions for cardiovascular formulations: progress from DFT modeling. [PDF]

Nanoscale Adv
Ocampo Cárdenas B, Román G, Noseda Grau E, Simonetti S.   +3 more
europepmc   +1 more source